XML 27 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 409.5 $ 1,345.0
Accounts receivable, less allowance for doubtful accounts of $4.4 and $4.7 405.3 439.1
Inventories 947.6 347.2
Prepaid expenses and other current assets 273.4 178.3
Total current assets 2,035.8 2,309.6
Property, plant and equipment, net 457.6 776.0
Intangible assets, net 2,843.8 5,448.4
Other assets 201.1 382.3
Total Assets 6,013.8 8,916.3
Current Liabilities:    
Current maturities of long-term debt 44.1 1,388.9
Accounts payable 114.0 123.0
Accrued payroll and payroll-related costs 49.5 84.6
Accrued interest 29.0 17.0
Accrued and other current liabilities 290.7 328.7
Total current liabilities 743.8 1,942.2
Pension and postretirement benefits 41.0 30.1
Environmental liabilities 35.8 43.0
Deferred income taxes 0.3 20.9
Other income tax liabilities 18.2 83.2
Other liabilities 78.4 85.8
Liabilities subject to compromise 0.0 6,397.7
Total Liabilities 4,400.1 8,602.9
Shareholders' Equity:    
Ordinary shares held in treasury at cost, none and 9,569,645 0.0 (1,616.1)
Additional paid-in capital 2,191.0 5,597.8
Retained deficit (588.2) (3,678.9)
Accumulated other comprehensive income (loss) 10.8 (8.3)
Total Shareholders' Equity 1,613.7 313.4
Total Liabilities and Shareholders' Equity 6,013.8 8,916.3
Cash and cash equivalents 409.5 1,345.0
Accounts receivable, less allowance for doubtful accounts of $4.4 and $4.7 405.3 439.1
Inventory, Net 947.6 347.2
Prepaid expenses and other current assets 273.4 178.3
Total current assets 2,035.8 2,309.6
Property, plant and equipment, net 457.6 776.0
Intangible Assets, Net (Excluding Goodwill) 2,843.8 5,448.4
Deferred Income Tax Assets, Net 475.5 0.0
Other assets 201.1 382.3
Assets 6,013.8 8,916.3
Current maturities of long-term debt 44.1 1,388.9
Accounts Payable, Current 114.0 123.0
Accrued payroll and payroll-related costs 49.5 84.6
Accrued interest 29.0 17.0
Acthar Gel-Related Settlement liability, Current 16.5 0.0
Opioid-Related Litigation Settlement liability, Current 200.0 0.0
Accrued and other current liabilities 290.7 328.7
Total current liabilities 743.8 1,942.2
Pension and postretirement benefits 41.0 30.1
Environmental liabilities 35.8 43.0
Deferred income taxes 0.3 20.9
Other income tax liabilities 18.2 83.2
Other Liabilities, Noncurrent 78.4 85.8
Liabilities subject to compromise 0.0 6,397.7
Total Liabilities 4,400.1 8,602.9
Treasury Stock, Value 0.0 1,616.1
Additional paid-in capital 2,191.0 5,597.8
Retained deficit (588.2) (3,678.9)
Accumulated Other Comprehensive Income (Loss), Net of Tax 10.8 (8.3)
Shareholders' equity 1,613.7 313.4
Total Liabilities and Shareholders' Equity 6,013.8 8,916.3
Acthar Gel-Related Settlement liability, Non-current 75.0 0.0
Opioid-Related Litigation Settlement liability, Non-current $ 379.9 0.0
Preferred shares, shares issued (in shares) 0  
Predecessor Reorganization    
Shareholders' Equity:    
Predecessor preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding $ 0.0 0.0
Predecessor ordinary shares, $0.20 par value, 500,000,000 authorized; 94,296,235 issued; 84,726,590 outstanding 0.0 0.0
Predecessor preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding 0.0 0.0
Predecessor ordinary shares, $0.20 par value, 500,000,000 authorized; 94,296,235 issued; 84,726,590 outstanding 0.0 0.0
Common Stock, Value, Outstanding 0.0 $ 18.9
Preferred shares, shares outstanding (in shares)   0
Preferred shares, shares issued (in shares)   0
Common Stock, Shares, Outstanding   84,726,590
Successor    
Shareholders' Equity:    
Predecessor preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding 0.0 $ 0.0
Predecessor ordinary shares, $0.20 par value, 500,000,000 authorized; 94,296,235 issued; 84,726,590 outstanding 0.0 0.0
Predecessor preferred shares, $0.20 par value, 500,000,000 authorized; none issued or outstanding 0.0 0.0
Predecessor ordinary shares, $0.20 par value, 500,000,000 authorized; 94,296,235 issued; 84,726,590 outstanding 0.0 0.0
Common Stock, Value, Outstanding $ 0.1 $ 0.0
Preferred shares, shares outstanding (in shares) 0  
Preferred shares, shares issued (in shares) 0  
Common Stock, Shares, Outstanding 13,170,932